Amphastar Pharmaceuticals(DE:29A)
€25.51-0.14 (-0.55%)
DE:29A
Amphastar Pharmaceuticals earnings date
€25.51
At close:-0.14 (-0.55%)
Amphastar Pharmaceuticals (29A) Q3 2021 Earnings Report
2 Followers
DE:29A Q3 2021 EPS Results
- Actual EPS
- EUR 0.41
- Consensus EPS
- EUR 0.21
- Beat/Miss
- Beat by +EUR 0.20
- One Year Ago EPS
- EUR 0.13
DE:29A Q3 2021 Revenue Results
- Actual Revenue
- EUR 100.46M
- Expected Revenue
- EUR 92.45M
- Beat/Miss
- Beat by +EUR 8.01M
- YoY Revenue Growth
- +34.48%
Earnings Announcement Details
- Quarter
- Q3 2021
- Date
- 11/08/2021
- Time
- After Close
- Conference Call
- Monday, November 8, 2021
DE:29A Upcoming Earnings
Amphastar Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q3 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:29A Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | 0.70- | 0.65 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 0.771.02 | 0.83 | 22.58% (+0.19) | |
| Aug 06, 2026 | 2026 (Q2) | 0.560.81 | 0.76 | 7.06% (+0.05) | |
| May 07, 2026 | 2026 (Q1) | 0.630.38 | 0.66 | -43.24% (-0.29) | |
| Feb 26, 2026 | 2025 (Q4) | 0.810.65 | 0.82 | -20.65% (-0.17) | |
| Nov 06, 2025 | 2025 (Q3) | 0.740.83 | 0.86 | -3.13% (-0.03) | |
| Aug 07, 2025 | 2025 (Q2) | 0.660.76 | 0.84 | -9.57% (-0.08) | |
| May 07, 2025 | 2025 (Q1) | 0.620.66 | 0.93 | -28.85% (-0.27) | |
| Feb 27, 2025 | 2024 (Q4) | 0.840.82 | 0.79 | 4.55% (+0.04) | |
| Nov 06, 2024 | 2024 (Q3) | 0.880.86 | 1.03 | -16.52% (-0.17) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
